Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-08-20 00:00:00 ET · period of report 2025-08-18 · accession 0001415889-25-022460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-20 | 2025-08-18 | KNSA | Tessari Eben | COO | M - OptEx | $8.83 | +6,500 | 56.4K | +13% | +$57.4K |
| DM | 2025-08-20 | 2025-08-18 | KNSA | Tessari Eben | COO | S - Sale+OE | $33.77 | -16.2K | 40.2K | -29% | -$547.1K |
| D | 2025-08-20 | 2025-08-18 | KNSA | Tessari Eben | COO | M - OptEx | $0.00 | -6,500 | 25.5K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-08-18 | M | A | 6,500 | $8.83 | 56,415 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-08-18 | S | D | 16,100 | $33.77 | 40,315 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.41 and $34.405. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 3 | Common | Class A Ordinary Share | 2025-08-18 | S | D | 100 | $34.44 | 40,215 | D | — | — | |
| 4 | Derivative | Share Option | 2025-08-18 | M | D | 6,500 | $0.00 | 25,500 | D | $8.83 · — to 2029-09-16 | 6,500 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |